Sorry for my rambling. I'm not specifically targeting RAC or any other biotech stock, but I’m curious about the incentives to invest in startups. It seems that every time the company reaches a new phase, the share price declines, and they need to raise capital for the next trials. Otherwise, it leads to dilution. So, why should someone be an early investor?
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.14 |
Change
-0.015(1.30%) |
Mkt cap ! $197.1M | |||
| Open | High | Low | Value | Volume |
| $1.16 | $1.16 | $1.13 | $170.4K | 148.8K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 5868 | $1.14 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.14 | 2062 | 1 |
View Market Depth
| Last trade - 16.10pm 13/06/2025 (20 minute delay) ? |
| RAC (ASX) Chart |